SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-24-000574
Filing Date
2024-04-29
Accepted
2024-04-29 16:05:35
Documents
10
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 e663528_def14a-arct.htm DEF 14A 771344
2 GRAPHIC image_001.jpg GRAPHIC 7608
3 GRAPHIC image_002.jpg GRAPHIC 43887
4 GRAPHIC image_003.jpg GRAPHIC 42835
5 GRAPHIC image_005.jpg GRAPHIC 1189
6 GRAPHIC image_006.jpg GRAPHIC 773
7 GRAPHIC image_007.jpg GRAPHIC 773
8 GRAPHIC image_008.jpg GRAPHIC 773
9 GRAPHIC image_009.jpg GRAPHIC 1025
10 GRAPHIC image_010.jpg GRAPHIC 886
  Complete submission text file 0001193805-24-000574.txt   911069
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38942 | Film No.: 24890603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)